Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015

Robert Soest; Ronald de Wit; Wytske van Weerden

doi:10.1016/j.eururo.2014.06.038

Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E71-E72
Journal	European Urology
Volume	66
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2014.06.038
Publication status	Published - 2014

Research programs

EMC MM-03-86-08

Access to Document

10.1016/j.eururo.2014.06.038

http://hdl.handle.net/1765/83512

Cite this

Soest, R., de Wit, R., & van Weerden, W. (2014). Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015. European Urology, 66(4), E71-E72. https://doi.org/10.1016/j.eururo.2014.06.038

Soest, Robert ; de Wit, Ronald ; van Weerden, Wytske. / Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015. In: European Urology. 2014 ; Vol. 66, No. 4. pp. E71-E72.

@article{9af86d033a054224aca80f32471d9c0f,

title = "Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015",

author = "Robert Soest and \{de Wit\}, Ronald and \{van Weerden\}, Wytske",

year = "2014",

doi = "10.1016/j.eururo.2014.06.038",

language = "Undefined/Unknown",

volume = "66",

pages = "E71--E72",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

Soest, R, de Wit, R & van Weerden, W 2014, 'Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015', European Urology, vol. 66, no. 4, pp. E71-E72. https://doi.org/10.1016/j.eururo.2014.06.038

Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015. / Soest, Robert; de Wit, Ronald ; van Weerden, Wytske.
In: European Urology, Vol. 66, No. 4, 2014, p. E71-E72.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015

AU - Soest, Robert

AU - de Wit, Ronald

AU - van Weerden, Wytske

PY - 2014

Y1 - 2014

U2 - 10.1016/j.eururo.2014.06.038

DO - 10.1016/j.eururo.2014.06.038

M3 - Article

SN - 0302-2838

VL - 66

SP - E71-E72

JO - European Urology

JF - European Urology

IS - 4

ER -

Soest R, de Wit R , van Weerden W. Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015. European Urology. 2014;66(4):E71-E72. doi: 10.1016/j.eururo.2014.06.038